Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients

Table 2

Clinical, laboratory, and echocardiographic data of patients in the two groups.

Variables	Group A (HBP with CV events); 36 patients	Group B (HBP without CV events); 44 patients
Age			0.06
Men	18 (50%)	20 (45.45%)	0.061
Women	18 (50%)	24 (54.54%)	0.052
SBP (mmHg)			0.023
DBP (mmHg)			0.024
BMI (kg/m^2)			0.03
Uric acid (mg/dL)			0.079
Creatinine (mg/dL)			0.246
Serum glucose (mg/dL)			0.338
Total cholesterol (mg/dL)			0.57
HDL cholesterol (mg/dL)			0.48
LDL cholesterol (mg/dL)			0.49
Triglycerides (mg/dL)			0.08
ST2 (ng/mL)	52.71 (41.7–99.45)	21.34 (15.17–44.24)	0.002
Ascending aorta (mm)			0.002
Left atrium size (mm)			0.056
Left atrium area (mm)			0.053
End-systolic interventricular septum (mm)			0.051
End-diastolic interventricular septum (mm)			0.188
End-systolic LV posterior wall (mm)			0.051
End-diastolic LV posterior wall (mm)			0.052
End-systolic LV size (mm)			0.224
End-diastolic LV size (mm)			0.306
Right ventricle size (mm)			0.074
Stroke volume (mL)			0.001
LV mass (g/m^2)			<0.001
LV mass index			<0.001
IVRT (ms)			0.009
			0.0043
EDT (ms)			0.0032
			0.0035